An important challenge in pancreatic islet transplantation in association with type 1 diabetes is to define automatic high-throughput assays for evaluation of human islet function. The physiological techniques presently used are amenable to small-scale experimental samples and produce descriptive results. The postgenomic era provides an opportunity to analyze biological processes on a larger scale, but the transition to highthroughput technologies is still a challenge. As a first step to implement high-throughput assays for the study of human islet function, we have developed two methodologies: multiple automated perifusion to determine islet hormone secretion and high-throughput kinetic imaging to examine islet cellular responses. Both technologies use fully automated devices that allow performing simultaneous experiments on multiple islet preparations. Our results illustrate that these technologies can be applied to study the functional status and explore the pharmacological profiles of islet cells. These methodologies will enable functional characterization of human islet preparations before transplantation and thereby provide the basis for the establishment of predictive tests for β-cell potency.
INTRODUCTION
preparations before transplantation is required to characterize islet cell viability and potency. We have recently developed a method to assess β-cell content and viabil-The endocrine cells of the islets of Langerhans in the human pancreas strictly maintain blood glucose levels at ity in human islets that predicts functional performance of islet preparations (8). By using laser scanning cytom-about 5 mM. Long-lasting increases (hyperglycemia) and decreases (hypoglycemia) in blood glucose concen-etry, we showed that we could examine the viability of large numbers of cells in a short time. We expect that tration can be fatal and are efficiently prevented by the secretion of the islet hormones insulin and glucagon, re-the availability of novel sophisticated techniques (6) will improve our ability to discriminate islet preparations that spectively. Death or malfunction of the insulin-secreting β-cells leads to diabetes mellitus. It is important to study are suitable for transplantation from those that should be discarded [for a discussion see (16) ]. human islets because relatively little is known about their function in normal physiology and during the pro-
The most powerful assays focus on the physiological processes of living cells. While several steps of the stim-gression to diabetes. Additionally, because islet transplantation is emerging as a new therapy to cure type 1 ulus-secretion coupling in islet cells have been studied using conventional methods, the transition to quantita-diabetes, examining functional parameters in vitro may predict islet potency after transplantation.
tive and high-throughput technologies has not been made. For instance, cellular imaging of cytoplasmic-free Numerous assays are being developed to optimize and assure quality of cells that are going to be used for Ca 2+ concentration, [Ca 2+ ] i , in islet cells is so far amenable only to small samples. Hormone secretion is gener-transplantation (2, 4, 7, 10, 14) . Assessment of human islet ally examined by using static incubation of islets, in step, as described previously (17) . Monkey, pig, rat, and mouse islet isolations were performed using modifica-which secretory responses are likely to be blunted by the low temporal resolution of the technique and/or by tions of the automated method for human islet isolation (17) , adapted for isolation of monkey islets (11) and desensitization due to unspecific accumulation of hormones. Dynamic changes in hormone secretion have mouse islets (3) . Human islets were dissociated into single cells using enzyme-free cell dissociation buffer (In-been determined using the islet perifusion technique but, as far as we know, this has been conducted on single vitrogen, Grand Island, NY). Islets and islets cells from all three species were cultured identically (37°C, 5% samples only. As such, these techniques are not suited to study the complexity of biological processes in islet CO 2 ) in CMRL medium-1066 (Invitrogen), niacinamide (10 mM, Sigma), ITS (BD Biosciences, San Jose, CA), cells on a large scale in order to establish whether an islet preparation is healthy, or to determine whether in-Zn 2 SO 4 (15 µM, Sigma), glutamax (Invitrogen), HEPES (25 mM, Sigma), fetal bovine serum (10%, Invitrogen), tervention and changes in culture conditions improve islet health prior to transplantation. Given the heterogene-and penicillin-streptomycin (Invitrogen). ity of islet cells and the variability between islets, Dynamic Measurements of Insulin reliable data about the functional status of an islet prepaand Glucagon Secretion ration can only be obtained with high-throughput assays.
Here we report two novel approaches that overcome A high-capacity, automated perifusion system (Bio rep Perifusion V2.0.0) was developed to dynamically many of the limitations of conventional physiological techniques. First, we have adapted the perifusion tech-measure hormone secretion from pancreatic islets ( Fig.  1) . A low pulsatility peristaltic pump pushed HEPES-nique to allow simultaneous measurements of hormone release from multiple islet samples in parallel. We have buffered solution (mM: 125 NaCl, 5.9 KCl, 2.56 CaCl 2 , 1 MgCl 2 , 25 HEPES, 0.1% BSA, pH 7.4; 100 µl/min) built an automated perifusion device that simultaneously collects the perifusates of up to eight islet samples with through a sample container harboring 100 pancreatic islets immobilized in Bio-Gel P-4 Gel (BioRad, Hercules, a temporal resolution of <1 min (Biorep Perifusion V2.0.0). The perifusates are then examined using Lu-CA). Except where otherwise noted, glucose concentration was adjusted to 3 mM for all experiments. Stimuli minex assays to determine the content of up to 100 analytes in a single reaction (xMAP technology). Second, were applied with the perifusion solution. The perifusate was collected in an automatic fraction collector designed we have used a kinetic imaging system, the BD Pathway TM 855 Bioimager, to examine islet cell populations for a multiwell plate format. The sample containers harboring the islets and the perifusion solutions were kept with fluorescence-based high content kinetic assays. Our results validate the application of these systems to study at 37°C in a built-in temperature controlled chamber, and the perifusate in the collecting plate was kept at islet health, pharmacological profiles of islet cells, and species differences in islet cell function.
<4°C, to preserve the integrity of the analytes in the perifusate. Perifusates were collected every minute.
MATERIALS AND METHODS

Determination of Hormone Release Islet Isolation and Culture
Human pancreata were obtained from multiorgan ca-Hormone release in the perifusate was determined with the human, rat, or mouse Endocrine LINCOplex daveric donors (n = 8). Monkey islets were isolated from cynomolgus monkeys (Macacca fascicularis; n = Kit following the manufacturer's instructions (Linco Research, St. Charles, MO). The biomolecular assays were 3) >4 years of age at the time of pancreas procurement. The pig pancreata (n = 3) were procured from the local performed on a Bio-Plex protein array system (Bio-Rad). This system is a flow-based dual laser system that slaughterhouse. Mice (C57Bl/6; n = 3) were killed by exposure to a rising concentration of CO 2 followed by simultaneously identifies and quantifies up to 100 different analytes in a single assay. cervical dislocation. All experimental protocols using mice were approved by the University of Miami Care Determinaton of [Ca 2+] i and Use Committee.
Islets from human pancreata were isolated at the Kinetic imaging of cytoplasmic-free Ca 2+ concentration ([Ca 2+ ] i ) was performed on a BD Pathway TM 855 cGMP Human Islet Cell Processing Facility of the Cell Transplant Center at the Miller School of Medicine, Bioimager (5) . Dispersed islet cells were plated at a density of 20,000 cells per well in black-sided 96-well University of Miami. The glands were cold preserved in University of Wisconsin solution (12). Islets were iso-plates coated with poly-D-lysin, and cultured overnight in CMRL medium. lated using a modification of the automated method (17) applying seven different lots of the enzyme Liberase HI For imaging, islet cells were immersed in HEPESbuffered solution (mM: 125 NaCl, 5.9 KCl, 2.56 CaCl 2 , (Roche, Indianapolis, IN) and a standard purification 1 MgCl 2 , 25 HEPES, 0.1% BSA, pH 7.4). Glucose was aging, islets were dissociated into single cells and plated in 96-well plates. Loaded sample containers and im-added at a basal concentration of 3 mM. Islet cells were incubated in Fura-2 AM (2 µM; 30 min). Cell plates aging plates were placed in fully automated systems for data acquisition. High-throughput kinetic imaging of were washed, leaving a residual volume of 100 µl, and transferred to the BD Pathway TM 855 Bioimager for ki-islet cell responses was performed on an automated fluorescence-based image acquisition system, the BD netic imaging. The atmosphere in the BD Pathway TM 855 Bioimager was kept at 37°C and 5% CO 2 . Stimuli were Pathway TM 855 Bioimager (BD Biosciences). Image aquisition and data analysis was done using BD Atto-prepared at 5× the final concentration such that addition of 25 µl would yield the desired concentration. Stimuli vision TM (Version 1,5,2,3; BD Biosciences). Perifusion assays were conducted on an automated perifusion de-were applied with an automated integrated disposable tip liquid handling. Islet cells loaded with Fura adjusted to change the time resolution of the experiment. Perifusates were processed for detection of three hor-Immunostaining mones in multiple, simultaneous assays using Luminex technology (Luminex Corporation, Austin, TX). Quanti-After kinetic imaging, the islet cells were fixed in 4% paraformaldehyde (10 min). After several rinses with tative data of the hormone concentrations were plotted as a function of time to obtain a dynamic profile of the OptiMax Wash Buffer (Biogenex, San Ramon, CA), cells were incubated in Universal Blocker Reagent secretory responses.
To validate these approaches, we damaged whole is-(5-10 min; Biogenex), rinsed again in OptiMax Wash Buffer, and incubated in Protein Block (20 min; Bio-lets or dispersed islet cells and determined whether changes in islet physiology could be detected. Islets genex). Thereafter, cells were incubated overnight with anti-insulin (1:500, Accurate Chemical & Scientific were treated for 2 h with different concentrations of staurosporine (10-10,000 nM), a potent, cell-permeable Corp., NY) or anti-glucagon (1:5000; Sigma) antibodies. Immunostaining was visualized using Alexa Fluor con-protein kinase C inhibitor that induces cell death. The different experimental groups were examined in parallel jugated secondary antibodies (1:500; Molecular Probes, Eugene, OR). Cell nuclei were stained with DAPI (Mo-for their capability to secrete insulin and glucagon using the perifusion assay. Incubation with staurosporine lecular Probes). The cell plate was placed back in the BD Pathway TM 855 Bioimager bioimager and images strongly reduced the insulin responses to high glucose concentration (11 mM) and the glucagon responses to were acquired and compared to those obtained during the kinetic imaging. It was always possible to correlate kainate (100 µM) in a concentration-dependent fashion (Fig. 2B, C) . We further incubated islets under anoxic the cells from the kinetic and immunostaining experiments. As a negative control, we substituted the primary conditions and found that insulin responses to stimulation with high glucose (11 mM) and KCl depolarization antibody with the serum of the animal used to raise this antibody. No staining was observed under these condi-were decreased (Fig. 2D-F) . The insulin response to glucose became smaller as the exposure to anoxia was tions. Digital images were compiled using Adobe Photoshop 7.0 (Adobe Systems Inc., San Jose CA). Only increased. After very long anoxia, insulin responses to KCl depolarization also became smaller. brightness and contrast were adjusted. We further exposed human islet cells to staurosporine RESULTS and tested whether changes in [Ca 2+ ] i responses could be detected using the BD Pathway TM 855 Bioimager. Islet High-throughput assays require automation and the precise coordination of various steps in an integrated cells placed in 96-well plates were exposed to a gradient of staurosporine concentrations. Islet cells were loaded workflow (15). Our experiments comprised three independent steps: sample preparation, data acquisition, and with the Ca 2+ indicator Fura-2 and stimulated with high glucose (11 mM). Islet cells were classified by the Atto-data analysis (Fig. 1) . Cultured islets were processed in parallel for perifusion assays and kinetic imaging. wells incubated with staurosporine (blue traces and bars tors of the AMPA/kainate type, human islets responded with increased secretion of glucagon but not insulin in Fig. 3B, C) . None of the human β-cells treated with the highest staurosporine concentration tested showed (Fig. 4B ). By using [Ca 2+ ] i imaging, we found that ATP and AMPA/kainate receptor agonists induced responses large responses (Fig. 3B, E) . These effects were concentration dependent (Fig. 3C-E) .
in islet cells (Fig. 5 ). Acetylcholine also induced large [Ca 2+ ] i responses. To establish which cell types were re-We used our functional approaches to obtain pharmacological profiles of human islet cells. We applied com-sponsive, we performed immunofluorescence for the islet hormones insulin and glucagon after [Ca 2+ ] i imaging. pounds that activate neurotransmitter receptors to test their effects in islet cells. We tested six agonists for ATP
We found that almost all cells sensitive to AMPA/kainate receptor agonists were also glucagon immunoreactive (purinergic) receptors and found that most of them elicited insulin responses in human islets (Fig. 4A) . Two (Fig. 5 ). ATP receptor agonists elicited [Ca 2+ ] i responses in insulin-immunoreactive cells and also in unstained of the agonists stimulated somatostatin secretion. The agonists had little effects on glucagon secretion. When cells. Small responses were also seen in a fraction of glucagon-immunoreactive cells. islets were incubated with agonists for glutamate recep- Figure 3 . Validation of the high-throughput kinetic imaging system to examine islet cellular responses. (A) Representative traces from individual human islet cells in a well of a 96-well plate showed a range of increases in [Ca 2+ ] i , in response to high glucose (11 mM). Blue traces are from cells that the system did not include as responsive, red and green traces are from cells that were respectively considered responsive and highly responsive. (B) Representative traces from islet cells in a well that was treated with staurosporine (10,000 nM). (C-E) Treatment with staurosporine (10-10,000 nM) increased the number of nonresponsive cells (C) and diminished the number of responsive (D) and highly responsive cells (E) in a concentration-dependent manner. Data other than control are pooled from at least 50 cells per well and three wells per condition.
We further used our assays to study species differ-that insulin responses to high glucose were smaller in islets from donors that had a longer history of type 2 ences with regard to islet function. Insulin responses to high glucose (11 mM) were different in the species stud-diabetes, indicating that insulin secretion becomes gradually impaired with progression of the disease (Fig. 6B ). ied (Fig. 6A ). Human and monkey islet responses showed an initial sharp peak followed by a sustained DISCUSSION response that lasted for the duration of the stimulus application. In contrast, insulin secretion in mouse islets
It is now possible to reverse type 1 diabetes and restore glucose homeostasis by transplanting islets from was only transiently increased by high glucose and returned to almost basal levels in the presence of the stim-deceased donors into individuals with the disease. This has opened new therapeutic avenues for the treatment of ulus. As an additional validation of the perifusion assay, we determined whether insulin secretion was impaired type 1 diabetes. In this context, it is particularly important to establish techniques that allow screening of drugs in islets from donors with type 2 diabetes. We found and compounds for effects on islet cell differentiation, ples and stimulating solutions are incubated in the same temperature-controlled chamber. The samples are col-islet cell signaling pathways, and islet cell pathology. Here we have shown how high-throughput assays can lected in a multiwell format plate. At the end of the experiment, the collecting plate is exposed in a way that be implemented for the study of islet cell function. Our results illustrate that our approaches can reliably mea-an external robot can transfer it to an automated analysis system. Second, when coupled to Luminex assays, peri-sure changes in the health status of human islet cells, determine pharmacological profiles of human islet cells, fusates can be examined for the content of up to 100 analytes. This means that hundreds of endpoints can be reveal species differences in islet function, and determine that function is impaired in islets from individuals measured with a time resolution of less than 1 min. This flexible technology enables screening of multiple drugs with type 2 diabetes.
Given its major implications for normal glucose ho-and compounds for effects on insulin and glucagon secretion as well as on the release of other active sub-meostasis, insulin secretion has been extensively studied. In most studies in the literature, insulin secretion stances such as cytokines. Given the large variability among preparations, using our device and approach, has been measured using static incubations of islets. This method has drawbacks, such as a low temporal res-which can examine up to eight samples in parallel, is likely to be successful to get robust information about olution and desensitization of secretory responses because secretory products accumulate around the endo-the secretory power of the actual islet preparation prior to transplantation. crine cells. These experiments do not provide any temporal information and results may be misleading be-Studies of complex biological processes require the use of high-throughput approaches. However, neither of cause the final state of the examined islets may be an indirect consequence of a series of sequential processes.
the existent, successfully applied techniques-protein analysis by mass spectrometry or transcription profiling Alternatively, dynamic hormone secretory responses have been measured with perifusion assays in which so-by DNA microarrays-provide information about functional cellular processes. In contrast, fluorescence-based lutions flowing through the islet preparation (perifusates) are collected for analysis (9). However, these imaging assays examine such processes in the physiological context of intact living cells (15). These assays, assays have been amenable only to small-scale experimental samples. Our perifusion approach overcomes however, are technically challenging and few applications of high-throughput microscopy have been reported most of these limitations. First, we have built a perifusion device that allows studying up to eight different (1, 13 ). Here we have introduced a new imaging platform using the BD Pathway TM 855 Bioimager and have dem-islet samples simultaneously. Stimulus delivery and collection of the perifusate are fully automated. The sam-onstrated that it can be implemented to study islet cell Fluorescence intensity is shown in pseudocolor scale. Arrows point at highly responsive cells. Bottom image shows the same well after immunostaining for insulin (red) and glucagon (green). The cells that were highly responsive to kainate were glucagon immunoreactive. (B) Traces of [Ca 2+ ] i responses from human islet cells in three wells exposed to either kainate (top), ATP (middle), or acetylcholine (bottom). Cells were identified with immunostaining after [Ca 2+ ] i imaging. Glucagon-immunoreactive cells (left column), but not insulin-immunoreactive cells (middle column), responded to kainate. ATP predominantly stimulated insulin-immunoreactive cells and unstained cells; only few glucagon-immunoreactive cells responded to ATP. Acetylcholine stimulated all cell types. Scales are the same for each row to allow response magnitudes to be compared. signaling and pathology. We have been able to obtain a how signaling pathways in islet cells change during the ontogeny of diabetes. preliminary pharmacological profile of islet cells that has revealed that kainate is a specific stimulus for α-Our high-throughput assays can further be used as diagnostic tools to test the efficacy of islets in the con-cells. Thus, kainate can be used in future high-throughput assays to identify human α-cells. By screening many text of islet transplantation as a therapy. Islets from different islet preparations could be screened in large scale drugs and compounds for their effects on [Ca 2+ ] i in islet cells, we will be able to identify additional cell-specific for their secretory and cellular responses to glucose and other stimuli. The temporal pattern as well as the magni-functional markers. More importantly, the systematic and quantitative functional characterization of islet cells tude of the responses could be indicators of islet health. Alternatively, the analyses could be focused on particu-will provide a biophysical fingerprint that will help us to understand the complex phenotype of endocrine cells lar signaling pathways that are selectively impaired in unhealthy islets, which could serve as biomarkers (e.g., of the islet. Such information could provide clues as to Figure 6 . The automated multiple perifusion assay revealed species differences in the insulin secretory profile and that this profile is altered in islets from individuals with type 2 diabetes. (A) Perifusion assays showed differences in insulin secretion in response to high glucose (11 mM) in four different species. (B) Perifusions of islets from individuals with type 2 diabetes showed that insulin secretion in response to high glucose (left) and KCl depolarization (right) decreased gradually with the progression of diabetes. voltage-gated Ca 2+ channels). These functional parame-proaches are likely not to be biological, but computational. A major issue is the analysis of massive amounts ters can then be validated as predictors of islet potency by correlating them with transplantation outcome. An-of data, and for many applications, the required software is still being developed. In our studies, for instance, ac-other application of our high-throughput assays is as screening tools to test the effects of compounds on islet quisition of data was much faster than data processing. Nevertheless, experiments that were typically carried out cell biology. Compounds could be tested together with well-characterized molecules in islet cells loaded with manually for weeks were done in a matter of days or hours. Our results give a glimpse of the potential of high-various fluorescent probes that cover a range of cellular phenotypes (e.g., mitochondrial membrane potential, throughput approaches. The flexibility and power of these approaches will make them key technologies for studying [Ca 2+ ] i , and intracellular pH) and then be classified based on the biological outcome and mechanism of action. In the complex biology of the islet endocrine cells. addition, based on the high degree of reproducibility, ACKNOWLEDGMENTS: Supported in part by NIH grants for our high-throughput assays can successfully be applied
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